Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Tsingke Showcases at AACR 2025 -- Advancing Global Cancer Research with Integrated Synthesis Solutions 2025-05-15 14:12
2025 ASGCT | Immunofoco's In Vivo CAR-T Technology Platform Debuts with Groundbreaking Innovations 2025-05-15 13:22
Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions 2025-05-15 13:04
Caliway Announces Successful EOP2 Meeting with the FDA for CBL-514 in Reduction of Abdominal Subcutaneous Fat 2025-05-14 13:38
GC Biopharma Receives FDA Approval for its U.S. Plasma Collection Center in Calexico, California 2025-05-14 13:21
Ubie and CMI Media Group Partner to Modernize DTC Advertising with Highly Personalized Consumer Campaigns in Women's Health, Hematology 2025-05-13 21:40
iNtRON Seeks a Strategic Partner to Explore the Promising Market for MRSA Decolonization 2025-05-13 20:00
Hyundai ADM Bio Voluntarily Withdraws IND for Clinical Study of Docetaxel Combination Cancer Therapy to Focus on Immunotherapy Strategy 2025-05-13 19:47
Strategic Partnership | Sanyou Bio and TransRecoBio Forge Strategic Alliance to Build a New Ecosystem for the Full Industry Chain 2025-05-13 18:00
United Imaging Expands its U.S. Portfolio with the FDA Clearance of the uAngio® AVIVA for Interventional X-Ray 2025-05-13 00:00
Grit Biotechnology Presents Multiple Scientific Breakthroughs at ASGCT 2025 Annual Meeting 2025-05-12 20:30
AccurEdit Therapeutics to present at the 2025 Annual Meeting of the American Society of Gene & Cell Therapy 2025-05-12 20:00
VUNO's AI-Powered Cardiac Arrest Risk Management System Earns CE MDR and UKCA Certifications 2025-05-12 15:22
CARsgen Announces Preliminary Clinical Data for Allogeneic BCMA CAR-T CT0596, Demonstrating Favorable Safety and Efficacy 2025-05-12 08:00
Skyline Therapeutics Presents Late-Breaking Abstract on SKG1108, a Novel Optogenetic Gene Therapy for Retinitis Pigmentosa, at ASGCT 2025 2025-05-11 00:00
Minghui Pharmaceutical Announces Strategic Partnership and Licensing Agreement with Qilu Pharmaceutical to Develop B7-H3 ADC in Greater China 2025-05-09 18:00
IASO Bio Receives Orphan Drug Designation from the Saudi Food and Drug Authority for Equecabtagene Autoleucel 2025-05-09 16:25
Datasea Pre-Announces Estimated Third Quarter Revenue of approximately $51.9 Million, up approximately 164.6% Year-over-Year 2025-05-08 21:30
From Patient to Pioneer: jinIX Supports Nathan Ehrlich's Mission for Rare Disease Research 2025-05-08 20:35
BioDlink Congratulates Junshi Biosciences on IND Approval of JS212, a Bispecific ADC Therapeutic Candidate 2025-05-08 20:30